Abstract
Various drug delivery systems are being rapidly developed for controlled drug release, improved efficacy, and reduced side effects with the goal of improving quality of life for patients and curing disease. Poly(lactic acid) (PLA) possesses numerous advantages compared with other polymers, including biocompatibility, biodegradability, low cost, environmental friendliness, and easily modified mechanical properties. These properties make PLA a promising polymer for biomedical applications. This review introduces the specific characteristics of PLA that enable its application for controlled drug delivery and describes different forms of PLA used for drug delivery, including nanoparticles, microspheres, hydrogels, electrospun fibers, and scaffolds. Previous work is summarized and future development is discussed.
References
Datta M, Via LE, Kamoun WS, Liu C, Chen W, Seano G, Weiner DM, Schimel D, England K, Martin JD, Gao X, Xu L, Barry CE, Jain RK (2015) Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc Natl Acad Sci 112(6):1827–1832
Chen J, Ding J, Xiao C, Zhuang X, Chen X (2015) Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers. Biomater Sci 3(7):988–1001
Gu X, Ding J, Zhang Z, Li Q, Zhuang X, Chen X (2015) Polymeric nanocarriers for drug delivery in osteosarcoma treatment. Curr Pharm Des 21(36):5187–5197
Pacardo DB, Ligler FS, Gu Z (2015) Programmable nanomedicine: synergistic and sequential drug delivery systems. Nanoscale 7(8):3381–3391
Ding J, Xiao C, Yan L, Tang Z, Zhuang X, Chen X, Jing X (2011) pH and dual redox responsive nanogel based on poly(L-glutamic acid) as potential intracellular drug carrier. J Control Release 152:E11–E13
Ding J, Chen J, Li D, Xiao C, Zhang J, He C, Zhuang X, Chen X (2013) Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro. J Mater Chem B 1(1):69–81
Xiao H, Qi R, Liu S, Hu X, Duan T, Zheng Y, Huang Y, Jing X (2011) Biodegradable polymer-cisplatin(IV) conjugate as a pro-drug of cisplatin(II). Biomaterials 32(30):7732–7739
Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee SK (2012) Drug delivery systems: an updated review. Int J Pharm Investig 2(1):2–11
Zhang Y, Chan HF, Leong KW (2013) Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 65(1):104–120
Ikada Y, Tsuji H (2000) Biodegradable polyesters for medical and ecological applications. Macromol Rapid Commun 21(3):117–132
Couvreur P (2013) Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev 65(1):21–23
Doppalapudi S, Jain A, Domb AJ, Khan W (2016) Biodegradable polymers for targeted delivery of anti-cancer drugs. Expert Opin Drug Deliv 13(6):891–909
Liu M, Li H, Luo G, Liu Q, Wang Y (2008) Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch Pharm Res 31(4):547–554
Feng C, Piao M, Li D (2016) Stereocomplex-reinforced PEGylated polylactide micelle for optimized drug delivery. Polymers 8(4):165
Ding GJ, Zhu YJ, Qi C, Lu BQ, Wu J, Chen F (2015) Porous microspheres of amorphous calcium phosphate: block copolymer templated microwave-assisted hydrothermal synthesis and application in drug delivery. J Colloid Interface Sci 443:72–79
Li J, Darabi M, Gu J, Shi J, Xue J, Huang L, Liu Y, Zhang L, Liu N, Zhong W, Zhang L, Xing M, Zhang L (2016) A drug delivery hydrogel system based on activin B for Parkinson’s disease. Biomaterials 102:72–86
Cheng M, Wang H, Zhang Z, Li N, Fang X, Xu S (2014) Gold nanorod-embedded electrospun fibrous membrane as a photothermal therapy platform. ACS Appl Mater Interfaces 6(3):1569–1575
Duan S, Yang X, Mei F, Tang Y, Li X, Shi Y, Mao J, Zhang H, Cai Q (2015) Enhanced osteogenic differentiation of mesenchymal stem cells on poly(L-lactide) nanofibrous scaffolds containing carbon nanomaterials. J Biomed Mater Res A 103(4):1424–1435
Pang XA, Zhuang XL, Tang ZH, Chen XS (2010) Polylactic acid (PLA): research, development and industrialization. Biotechnol J 5(11):1125–1136
Chang FY, Teng PT, Tsai TH (2013) Property measurement and processing parameter optimization for polylactide micro structure fabrication by thermal imprint. Jpn J Appl Phys 52(6S):06GJ09
Arrnentano I, Bitinis N, Fortunati E, Mattioli S, Rescignano N, Verdejo R, Lopez-Manchado MA, Kenny JM (2013) Multifunctional nanostructured PLA materials for packaging and tissue engineering. Prog Polym Sci 38(10–11):1720–1747
Lasprilla AJ, Martinez GA, Lunelli BH, Jardini AL, Filho RM (2012) Poly-lactic acid synthesis for application in biomedical devices – A review. Biotechnol Adv 30(1):321–328
Manome A, Okada S, Uchimura T, Komagata K (1998) The ratio of L-form to D-form of lactic acid as a criteria for the identification of lactic acid bacteria. J Gen Appl Microbiol 44(6):371–374
Wang J, Xu W, Ding J, Lu S, Wang X, Wang C, Chen X (2015) Cholesterol-enhanced polylactide-based stereocomplex micelle for effective delivery of doxorubicin. Materials 8(1):216–230
Wang J, Shen K, Xu W, Ding J, Wang X, Liu T, Wang C, Chen X (2015) Stereocomplex micelle from nonlinear enantiomeric copolymers efficiently transports antineoplastic drug. Nanoscale Res Lett 10(1):206
Ajiro H, Kuroda A, Kan K, Akashi M (2015) Stereocomplex film using triblock copolymers of polylactide and poly(ethylene glycol) retain paxlitaxel on substrates by an aqueous inkjet system. Langmuir 31(38):10583–10589
Chen C, Lv G, Pan C, Song M, Wu C, Guo D, Wang X, Chen B, Gu Z (2007) Poly(lactic acid) (PLA) based nanocomposites – A novel way of drug-releasing. Biomed Mater 2(4):L1–L4
Lasprilla AJR, Martinez GAR, Lunelli BH, Jardini AL, Maciel R (2010) Biomaterials for application in bone tissue engineering. J Biotechnol 150:S455–S455
Auras R, Harte B, Selke S (2004) An overview of polylactides as packaging materials. Macromol Biosci 4(9):835–864
Gupta AP, Kumar V (2007) New emerging trends in synthetic biodegradable polymers – polylactide: a critique. Eur Polym J 43(10):4053–4074
Townshend A (1985) Anal Chim Acta 177:304
Di Martino A, Sedlarik V (2014) Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy. Int J Pharm 474(1–2):134–145
Hou Z, Li L, Zhan C, Zhu P, Chang D, Jiang Q, Ye S, Yang X, Li Y, Xie L, Zhang Q (2012) Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system: 10-Hydroxycamptothecin loaded PLA microbubbles. Ultrasonics 52(7):836–841
Li J, Sabliov C (2013) PLA/PLGA nanoparticles for delivery of drugs across the blood-brain barrier. Nanotechnol Rev 2(3):241–257
Sun D, Ding J, Xiao C, Chen J, Zhuang X, Chen X (2015) Drug delivery: pH-responsive reversible PEGylation improves performance of antineoplastic agent (Adv. Healthcare Mater. 6/2015). Adv Healthc Mater 4(6):786–786
Wu Y-L, Chen X, Wang W, Loh XJ (2016) Engineering bioresponsive hydrogels toward healthcare applications. Macromol Chem Phys 217(2):175–188
Zhang J, Wang X, Liu T, Liu S, Jing X (2016) Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer. Drug Deliv 23(3):794–800
Li Z, Zhang FL, Pan LL, Zhu XL, Zhang ZZ (2015) Preparation and characterization of injectable mitoxantrone poly(lactic acid)/fullerene implants for in vivo chemo-photodynamic therapy. J Photochem Photobiol B Biol 149:51–57
Fernandez K, Aburto J, von Plessing C, Rockel M, Aspe E (2016) Factorial design optimization and characterization of poly-lactic acid (PLA) nanoparticle formation for the delivery of grape extracts. Food Chem 207:75–85
Feng X, Gao X, Kang T, Jiang D, Yao J, Jing Y, Song Q, Jiang X, Liang J, Chen J (2015) Mammary-derived growth inhibitor targeting peptide-modified PEG-PLA nanoparticles for enhanced targeted glioblastoma therapy. Bioconjug Chem 26(8):1850–1861
Dou S, Yang XZ, Xiong MH, Sun CY, Yao YD, Zhu YH, Wang J (2014) ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2(+) breast cancer. Adv Healthc Mater 3(11):1792–1803
Yao L, Song Q, Bai W, Zhang J, Miao D, Jiang M, Wang Y, Shen Z, Hu Q, Gu X, Huang M, Zheng G, Gao X, Hu B, Chen J, Chen H (2014) Facilitated brain delivery of poly(ethylene glycol)-poly(lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound. Biomaterials 35(10):3384–3395
Liu B, Han SM, Tang XY, Han L, Li CZ (2014) Cervical cancer gene therapy by gene loaded PEG-PLA nanomedicine. Asian Pac J Cancer Prev 15(12):4915–4918
Yao W, Xu P, Pang Z, Zhao J, Chai Z, Li X, Li H, Jiang M, Cheng H, Zhang B, Cheng N (2014) Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs. Int J Nanomedicine 9:3963–3970
Amoozgar Z, Yeo Y (2012) Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(2):219–233
Yeh P-YJ, Kainthan RK, Zou Y, Chiao M, Kizhakkedathu JN (2008) Self-assembled monothiol-terminated hyperbranched polyglycerols on a gold surface: a comparative study on the structure, morphology, and protein adsorption characteristics with linear poly(ethylene glycol)s. Langmuir 24(9):4907–4916
Deng Y, Saucier-Sawyer JK, Hoimes CJ, Zhang JW, Seo YE, Andrejecsk JW, Saltzman WM (2014) The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles. Biomaterials 35(24):6595–6602
Yamakawa I, Tsushima Y, Machida R, Watanabe S (1992) Invitro and invivo release of poly(DL-lactic acid) microspheres containing neurotensin analog prepared by novel oil-in-water solvent evaporation method. J Pharm Sci 81(8):808–811
Jing Z, Xu XY, Chen XS, Liang QZ, Bian XC, Yang LX, Jing XB (2003) Biodegradable electrospun fibers for drug delivery. J Control Release 92(3):227–231
Maestrelli F, Bragagni M, Mura P (2016) Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: a review. J Drug Delivery Sci Technol 32:192–205
Zhu Z (2013) Effects of amphiphilic diblock copolymer on drug nanoparticle formation and stability. Biomaterials 34(38):10238–10248
Patel T, Zhou JB, Piepmeier JM, Saltzman WM (2012) Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 64(7):701–705
Ishihara T, Takahashi M, Higaki M, Mizushima Y (2009) Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticles. Int J Pharm 365(1–2):200–205
Choonara YE, Kumar P, Modi G, Pillay V (2016) Improving drug delivery technology for treating neurodegenerative diseases. Expert Opin Drug Deliv 13(7):1029–1043
Rao KS, Reddy MK, Horning JL, Labhasetwar V (2008) TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29(33):4429–4438
Sun WQ, Xie CS, Wang HF, Hu Y (2004) Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials 25(15):3065–3071
Kulkarni SA, Feng SS (2011) Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier. Nanomedicine 6(2):377–394
Lu W, Wan J, She ZJ, Jiang XG (2007) Brain delivery property and accelerated blood clearance of cationic albumin conjugated PEGylated nanoparticle. J Control Release 118(1):38–53
Gan CW, Feng SS (2010) Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 31(30):7748–7757
Hashizume R, Gupta N (2010) Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery. Curr Opin Mol Ther 12(2):168–175
Jain DS, Bajaj AN, Athawale RB, Shikhande SS, Pandey A, Goel PN, Gude RP, Patil S, Raut P (2016) Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route. Mater Sci Eng C 63:411–421
Xia HM, Gao XL, Gu GZ, Liu ZY, Zeng N, Hu QY, Song QX, Yao L, Pang ZQ, Jiang XG, Chen J, Chen HZ (2011) Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. Biomaterials 32(36):9888–9898
Li Y, Du Y, Liu X, Zhang Q, Jing L, Liang X, Chi C, Dai Z, Tian J (2015) Monitoring tumor targeting and treatment effects of IRDye 800CW and GX1-conjugated polylactic acid nanoparticles encapsulating endostar on glioma by optical molecular imaging. Mol Imaging 14:356–365
Miller T, Breyer S, van Colen G, Mier W, Haberkorn U, Geissler S, Voss S, Weigandt M, Goepferich A (2013) Premature drug release of polymeric micelles and its effects on tumor targeting. Int J Pharm 445(1–2):117–124
Mishra GP, Nguyen D, Alani AW (2013) Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade. Mol Pharm 10(5):2071–2078
Xu W, Ding J, Li L, Xiao C, Zhuang X, Chen X (2015) Acid-labile boronate-bridged dextran-bortezomib conjugate with up-regulated hypoxic tumor suppression. Chem Commun 51(31):6812–6815
Liu Y, Wang X, Sun CY, Wang J (2015) Delivery of mitogen-activated protein kinase inhibitor for hepatocellular carcinoma stem cell therapy. ACS Appl Mater Interfaces 7(1):1012–1020
Zhang X, Yang Y, Liang X, Zeng X, Liu Z, Tao W, Xiao X, Chen H, Huang L, Mei L (2014) Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics 4(11):1085–1095
Yang A, Liu Z, Yan B, Zhou M, Xiong X (2016) Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22. Drug Deliv 23(5):1699–1706
Liu Y, Zhu YH, Mao CQ, Dou S, Shen S, Tan ZB, Wang J (2014) Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles. J Control Release 192:114–121
Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J (2011) Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. J Control Release 156(2):203–211
Contreras J, Xie J, Chen YJ, Pei H, Zhang G, Fraser CL, Hamm-Alvarez SF (2010) Intracellular uptake and trafficking of difluoroboron dibenzoylmethane-polylactide nanoparticles in HeLa cells. ACS Nano 4(5):2735–2747
Laroui H, Viennois E, Xiao B, Canup BSB, Geem D, Denning TL, Merlin D (2014) Fab’-bearing siRNA TNF alpha-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis. J Control Release 186:41–53
Kaffashi B, Davoodi S, Oliaei E (2016) Poly(epsilon-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: a long-term antibacterial bionanocomposite with sustained release. Int J Pharm 508(1–2):10–21
Sun C, Wang X, Chen D, Lin X, Yu D, Wu H (2016) Dexamethasone loaded nanoparticles exert protective effects against cisplatin-induced hearing loss by systemic administration. Neurosci Lett 619:142–148
Pinon-Segundo E, Ganem-Quintanar A, Alonso-Perez V, Quintanar-Guerrero D (2005) Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int J Pharm 294(1–2):217–232
Chen L, Liu L, Li C, Tan Y, Zhang G (2011) A new growth factor controlled drug release system to promote healing of bone fractures: nanospheres of recombinant human bone morphogenetic-2 and polylactic acid. J Nanosci Nanotechnol 11(4):3107–3114
Rancan F, Papakostas D, Hadam S, Hackbarth S, Delair T, Primard C, Verrier B, Sterry W, Blume-Peytavi U, Vogt A (2009) Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res 26(8):2027–2036
Sakai T, Kohno H, Ishihara T, Higaki M, Saito S, Matsushima M, Mizushima Y, Kitahara K (2006) Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res 82(4):657–663
Molina J, Urbina J, Gref R, Brener Z, Rodrigues Junior JM (2001) Cure of experimental Chagas’ disease by the bis-triazole DO870 incorporated into ‘stealth’ polyethyleneglycol-polylactide nanospheres. J Antimicrob Chemother 47(1):101–104
Kohane DS (2007) Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng 96(2):203–209
Freiberg S, Zhu XX (2004) Polymer microspheres for controlled drug release. Int J Pharm 282(1–2):1–18
Li S (1999) Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomed Mater Res 48(3):342–353
Floyd JA, Galperin A, Ratner BD (2015) Drug encapsulated polymeric microspheres for intracranial tumor therapy: a review of the literature. Adv Drug Deliv Rev 91:23–37
Edlund U, Albertsson AC (2002) Degradable polymer microspheres for controlled drug delivery. In: Degradable aliphatic polyesters, Advances in polymer science, vol 157. Springer, Heidelberg, pp 67–112
Guan Q, Chen W, Hu X (2015) Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation. Drug Des Devel Ther 9:791–798
Lu J, Hou R, Yang Z, Tang Z (2015) Development and characterization of drug-loaded biodegradable PLA microcarriers prepared by the electrospraying technique. Int J Mol Med 36(1):249–254
Chen X, Yang Z, Sun R, Mo Z, Jin G, Wei F, Hu J, Guan W, Zhong N (2014) Preparation of lung-targeting, emodin-loaded polylactic acid microspheres and their properties. Int J Mol Sci 15(4):6241–6251
Falconi M, Focaroli S, Teti G, Salvatore V, Durante S, Nicolini B, Orienti I (2014) Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide. J Microencapsul 31(1):41–48
Pinto E, Zhang B, Song S, Bodor N, Buchwald P, Hochhaus G (2010) Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant. Pharmazie 65(6):429–435
Umeki N, Sato T, Harada M, Takeda J, Saito S, Iwao Y, Itai S (2010) Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release. Int J Pharm 392(1–2):42–50
Rafat M, Cleroux CA, Fong WG, Baker AN, Leonard BC, O’Connor MD, Tsilfidis C (2010) PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells. Biomaterials 31(12):3414–3421
Sheshala R, Peh KK, Darwis Y (2009) Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery. Drug Dev Ind Pharm 35(11):1364–1374
Ding LY, Xia PF, Yang CQ, Lin YL, Wang J (2007) Preparation and evaluation of sustained-release microsphere of Sanguis Draconis in vitro. Zhongguo Zhong Yao Za Zhi 32(5):388–390
Ren J, Yu X, Ren T, Hong H (2007) Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres. J Mater Sci Mater Med 18(8):1481–1487
Matsumoto A, Matsukawa Y, Suzuki T, Yoshino H (2005) Drug release characteristics of multi-reservoir type microspheres with poly(DL-lactide-co-glycolide) and poly(DL-lactide). J Control Release 106(1–2):172–180
Chen A, Dang T, Wang S, Tang N, Liu Y, Wu W (2014) The in vitro and in vivo anti-tumor effects of MTX-Fe3O4-PLLA-PEG-PLLA microspheres prepared by suspension-enhanced dispersion by supercritical CO2. Sci China Life Sci 57(7):698–709
Zhao H, Wu F, Cai Y, Chen Y, Wei L, Liu Z, Yuan W (2013) Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres. Int J Pharm 450(1–2):235–240
Zhou JY, Wang XM, Zhang QQ, Ye SF (2009) Efficacy of intraperitoneally injected epirubicin-loaded poly (d, l)-lactic acid microspheres alone or combined with free epirubicin in treating hepatocellular carcinoma in mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 31(5):603–606
Ciftci K, Hincal AA, Kas HS, Ercan TM, Sungur A, Guven O, Ruacan S (1997) Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres. Pharm Dev Technol 2(2):151–160
Kuang LR, Yang DJ, Inoue T, Liu WC, Wallace S, Wright KC (1996) Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity. Anti-Cancer Drugs 7(2):220–227
Xia D, Yao H, Liu Q, Xu L (2012) Preparation of microspheres encapsulating a recombinant TIMP-1 adenovirus and their inhibition of proliferation of hepatocellular carcinoma cells. Asian Pac J Cancer Prev 13(12):6363–6368
Lu J, Jackson JK, Gleave ME, Burt HM (2008) The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Cancer Chemother Pharmacol 61(6):997–1005
Lu Y, Lin P, Lu B, Wang J, Zhang J, Huang X (2000) Studies on release characteristics and cytotoxicity of 5-fluorouracil loaded polylactide microspheres on lung cancer cell lines. Zhongguo Fei Ai Za Zhi 3(6):432–434
Burt HM, Jackson JK, Bains SK, Liggins RT, Oktaba AM, Arsenault AL, Hunter WL (1995) Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (D,L-lactic acid). Cancer Lett 88(1):73–79
Chandy T, Das GS, Rao GHR (2000) 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul 17(5):625–638
Macha IJ, Cazalbou S, Ben-Nissan B, Harvey KL, Milthorpe B (2015) Marine structure derived calcium phosphate-polymer biocomposites for local antibiotic delivery. Mar Drugs 13(1):666–680
Jain JP, Kumar N (2010) Development of amphotericin B loaded polymersomes based on (PEG)(3)-PLA co-polymers: factors affecting size and in vitro evaluation. Eur J Pharm Sci 40(5):456–465
Huang YY, Chung TW (2001) Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer. J Microencapsul 18(4):457–465
Sharma R, Muttil P, Yadav AB, Rath SK, Bajpai VK, Mani U, Misra A (2007) Uptake of inhalable microparticles affects defence responses of macrophages infected with mycobacterium tuberculosis H37Ra. J Antimicrob Chemother 59(3):499–506
Selek H, Sahin S, Ercan MT, Sargon M, Hincal AA, Kas HS (2003) Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres. J Microencapsul 20(2):261–271
Guiziou B, Armstrong DJ, Elliott PNC, Ford JL, Rostron C (1996) Investigation of in-vitro release characteristics of NSAID-loaded polylactic acid microspheres. J Microencapsul 13(6):701–708
Zha J, Chi XW, Yu XL, Liu XM, Liu DQ, Zhu J, Ji H, Liu RT (2016) Interleukin-1 beta-targeted vaccine improves glucose control and β-cell function in a diabetic KK-A(y) mouse model. PLoS One 11(5):16
Anugraha G, Madhumathi J, Prita PJJ, Kaliraj P (2015) Biodegradable poly-L-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens. Eur J Pharmacol 747:174–180
Pavot V, Berthet M, Resseguier J, Legaz S, Handke N, Gilbert SC, Paul S, Verrier B (2014) Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery. Nanomedicine 9(17):2703–2718
Qiu SH, Wei Q, Liang ZL, Ma GH, Wang LY, An WQ, Ma XW, Fang X, He P, Li HM, Hu ZY (2014) Biodegradable polylactide microspheres enhance specific immune response induced by hepatitis B surface antigen. Hum Vaccin Immunother 10(8):2350–2356
Pandit S, Cevher E, Zariwala MG, Somavarapu S, Alpar HO (2007) Enhancement of immune response of HBsAg loaded poly(L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan. J Microencapsul 24(6):539–552
Zhou SB, Liao XY, Li XH, Deng XM, Li H (2003) Poly-D,L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J Control Release 86(2–3):195–205
Wang K, Li WF, Xing JF, Dong K, Gao Y (2012) Preliminary assessment of the safety evaluation of novel pH-sensitive hydrogel. Eur J Pharm Biopharm 82(2):332–339
Markland P, Zhang Y, Amidon GL, Yang VC (1999) A pH- and ionic strength-responsive polypeptide hydrogel: synthesis, characterization, and preliminary protein release studies. J Biomed Mater Res 47(4):595–602
Gong C, Shi S, Dong P, Kan B, Gou M, Wang X, Li X, Luo F, Zhao X, Wei Y, Qian Z (2009) Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm 365(1–2):89–99
Fu SZ, Li Z, Fan JM, Meng XH, Shi K, Qu Y, Yang LL, Wu JB, Fan J, Luot F, Qian ZY (2014) Biodegradable and thermosensitive monomethoxy poly(ethylene glycol)-poly(lactic acid) hydrogel as a barrier for prevention of post-operative abdominal adhesion. J Biomed Nanotechnol 10(3):427–435
Fan R, Deng X, Zhou L, Gao X, Fan M, Wang Y, Guo G (2014) Injectable thermosensitive hydrogel composite with surface-functionalized calcium phosphate as raw materials. Int J Nanomedicine 9:615–626
Basu A, Kunduru KR, Doppalapudi S, Domb AJ, Khan W (2016) Poly(lactic acid) based hydrogels. Adv Drug Deliv Rev 107:192–205
Lai PL, Hong DW, Ku KL, Lai ZT, Chu IM (2014) Novel thermosensitive hydrogels based on methoxy polyethylene glycol-co-poly(lactic acid-co-aromatic anhydride) for cefazolin delivery. Nanomedicine 10(3):553–560
Molina I, Li S, Martinez MB, Vert M (2001) Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type. Biomaterials 22(4):363–369
He X, Ma J, Jabbari E (2010) Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels. Int J Pharm 390(2):107–116
Shen W, Luan J, Cao L, Sun J, Yu L, Ding J (2015) Thermogelling polymer-platinum(IV) conjugates for long-term delivery of cisplatin. Biomacromolecules 16(1):105–115
Fan R, Tong A, Li X, Gao X, Mei L, Zhou L, Zhang X, You C, Guo G (2015) Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. Int J Nanomedicine 10:7291–7305
Manaka T, Suzuki A, Takayama K, Imai Y, Nakamura H, Takaoka K (2011) Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 32(36):9642–9648
Nelson DM, Hashizume R, Yoshizumi T, Blakney AK, Ma Z, Wagner WR (2014) Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy. Biomacromolecules 15(1):1–11
Song Z, Shi B, Ding J, Zhuang X, Zhang X, Fu C, Chen X (2015) A comparative study of preventing postoperative tendon adhesion using electrospun polyester membranes with different degradation kinetics. Sci China Chem 58(7):1159–1168
Zhang ZZ, Jiang D, Wang SJ, Qi YS, Ding JX, Yu JK, Chen XS (2015) Scaffolds drive meniscus tissue engineering. RSC Adv 5(95):77851–77859
Wang X, Shan H, Wang J, Hou Y, Ding J, Chen Q, Guan J, Wang C, Chen X (2015) Characterization of nanostructured ureteral stent with gradient degradation in a porcine model. Int J Nanomedicine 10:3055–3064
Zhang J, Liu H, Ding JX, Zhuang XL, Chen XS, Li ZM (2015) Annealing regulates the performance of an electrospun poly(ε-caprolactone) membrane to accommodate tissue engineering. RSC Adv 5(41):32604–32608
Zhang J, Liu H, Xu H, Ding JX, Zhuang XL, Chen XS, Chang F, Xu JZ, Li ZM (2014) Molecular weight-modulated electrospun poly(ε-caprolactone) membranes for postoperative adhesion prevention. RSC Adv 4(79):41696–41704
Shi B, Ding J, Wei J, Fu C, Zhuang X, Chen X (2015) Drug-incorporated electrospun fibers efficiently prevent postoperative adhesion. Curr Pharm Des 21(15):1960–1966
Jin HJ, Fridrikh SV, Rutledge GC, Kaplan DL (2002) Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules 3(6):1233–1239
Chen M, Li YF, Besenbacher F (2014) Electrospun nanofibers-mediated on-demand drug release. Adv Healthc Mater 3(11):1721–1732
Zhang J, Wang X, Liu T, Liu S, Jing X (2016) Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer. Drug Deliv 23(3):784–790
Zhang Z, Liu S, Xiong H, Jing X, Xie Z, Chen X, Huang Y (2015) Electrospun PLA/MWCNTs composite nanofibers for combined chemo- and photothermal therapy. Acta Biomater 26:115–123
Zong X, Li S, Chen E, Garlick B, Kim KS, Fang D, Chiu J, Zimmerman T, Brathwaite C, Hsiao BS, Chu B (2004) Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes. Ann Surg 240(5):910–915
Chen CH, Chen SH, Shalumon KT, Chen JP (2015) Dual functional core-sheath electrospun hyaluronic acid/polycaprolactone nanofibrous membranes embedded with silver nanoparticles for prevention of peritendinous adhesion. Acta Biomater 26:225–235
Liu S, Zhao J, Ruan H, Wang W, Wu T, Cui W, Fan C (2013) Antibacterial and anti-adhesion effects of the silver nanoparticles-loaded poly(L-lactide) fibrous membrane. Mater Sci Eng C 33(3):1176–1182
Hu C, Liu S, Zhang Y, Li B, Yang H, Fan C, Cui W (2013) Long-term drug release from electrospun fibers for in vivo inflammation prevention in the prevention of peritendinous adhesions. Acta Biomater 9(7):7381–7388
Jiang S, Zhao X, Chen S, Pan G, Song J, He N, Li F, Cui W, Fan C (2014) Down-regulating ERK1/2 and SMAD2/3 phosphorylation by physical barrier of celecoxib-loaded electrospun fibrous membranes prevents tendon adhesions. Biomaterials 35(37):9920–9929
Liu S, Hu C, Li F, Li XJ, Cui W, Fan C (2013) Prevention of peritendinous adhesions with electrospun ibuprofen-loaded poly(L-lactic acid)-polyethylene glycol fibrous membranes. Tissue Eng Part A 19(3–4):529–537
Liu S, Qin M, Hu C, Wu F, Cui W, Jin T, Fan C (2013) Tendon healing and anti-adhesion properties of electrospun fibrous membranes containing bFGF loaded nanoparticles. Biomaterials 34(19):4690–4701
Wang H, Li M, Hu J, Wang C, Xu S, Han CC (2013) Multiple targeted drugs carrying biodegradable membrane barrier: anti-adhesion, hemostasis, and anti-infection. Biomacromolecules 14(4):954–961
Sreerekha PR, Menon D, Nair SV, Chennazhi KP (2013) Fabrication of electrospun poly(lactide-co-glycolide)-fibrin multiscale scaffold for myocardial regeneration in vitro. Tissue Eng Part A 19(7–8):849–859
Jia L, Prabhakaran MP, Qin X, Ramakrishna S (2013) Stem cell differentiation on electrospun nanofibrous substrates for vascular tissue engineering. Mater Sci Eng C Mater Biol Appl 33(8):4640–4650
Vadala G, Mozetic P, Rainer A, Centola M, Loppini M, Trombetta M, Denaro V (2012) Bioactive electrospun scaffold for annulus fibrosus repair and regeneration. Eur Spine J 21(Suppl 1):S20–S26
Ahire JJ, Neppalli R, Heunis TD, van Reenen AJ, Dicks LM (2014) 2,3-Dihydroxybenzoic acid electrospun into poly(D,L-lactide) (PDLLA)/poly(ethylene oxide) (PEO) nanofibers inhibited the growth of gram-positive and gram-negative bacteria. Curr Microbiol 69(5):587–593
Llorens E, Calderon S, del Valle LJ, Puiggali J (2015) Polybiguanide (PHMB) loaded in PLA scaffolds displaying high hydrophobic, biocompatibility and antibacterial properties. Mater Sci Eng C Mater Biol Appl 50:74–84
Spasova M, Manolova N, Paneva D, Mincheva R, Dubois P, Rashkov I, Maximova V, Danchev D (2010) Polylactide stereocomplex-based electrospun materials possessing surface with antibacterial and hemostatic properties. Biomacromolecules 11(1):151–159
Ni P, Fu S, Fan M, Guo G, Shi S, Peng J, Luo F, Qian Z (2011) Preparation of poly(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue engineering. Int J Nanomedicine 6:3065–3075
Seyedjafari E, Soleimani M, Ghaemi N, Shabani I (2010) Nanohydroxyapatite-coated electrospun poly(L-lactide) nanofibers enhance osteogenic differentiation of stem cells and induce ectopic bone formation. Biomacromolecules 11(11):3118–3125
Kobsa S, Kristofik NJ, Sawyer AJ, Bothwell AL, Kyriakides TR, Saltzman WM (2013) An electrospun scaffold integrating nucleic acid delivery for treatment of full-thickness wounds. Biomaterials 34(15):3891–3901
Canton I, McKean R, Charnley M, Blackwood KA, Fiorica C, Ryan AJ, MacNeil S (2010) Development of an ibuprofen-releasing biodegradable PLA/PGA electrospun scaffold for tissue regeneration. Biotechnol Bioeng 105(2):396–408
Santoro M, Shah SR, Walker JL, Mikos AG (2016) Poly(lactic acid) nanofibrous scaffolds for tissue engineering. Adv Drug Deliv Rev 107:206–212
Liu DH, Ding JX, Xu WG, Song XF, Zhuang XL, Chen XS (2014) Stereocomplex micelles based on 4-armed poly ( ethylene glycol )-polylactide enantiomeric copolymers for drug delivery. Acta Polym Sin 9:1265–1273
Saffer EM, Tew GN, Bhatia SR (2011) Poly(lactic acid)-poly(ethylene oxide) block copolymers: new directions in self-assembly and biomedical applications. Curr Med Chem 18(36):5676–5686
Zhou R, Xu W, Chen F, Qi C, Lu BQ, Zhang H, Wu J, Qian QR, Zhu YJ (2014) Amorphous calcium phosphate nanospheres/polylactide composite coated tantalum scaffold: facile preparation, fast biomineralization and subchondral bone defect repair application. Colloids Surf B Biointerfaces 123:236–245
Pelto J, Bjorninen M, Palli A, Talvitie E, Hyttinen J, Mannerstrom B, Suuronen Seppanen R, Kellomaki M, Miettinen S, Haimi S (2013) Novel polypyrrole-coated polylactide scaffolds enhance adipose stem cell proliferation and early osteogenic differentiation. Tissue Eng Part A 19(7–8):882–892
Niu X, Fan Y, Liu X, Li X, Li P, Wang J, Sha Z, Feng Q (2011) Repair of bone defect in femoral condyle using microencapsulated chitosan, nanohydroxyapatite/collagen and poly(L-lactide)-based microsphere-scaffold delivery system. Artif Organs 35(7):E119–E128
Hu J, Sun X, Ma H, Xie C, Chen YE, Ma PX (2010) Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials 31(31):7971–7977
Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, Nakamura T, Fujita S, Takeda S, Motohara S, Uehata H (2003) Biodegradable stents as a platform to drug loading. Int J Cardiovasc Interv 5(1):13–16
Haddad T, Noel S, Liberelle B, El Ayoubi R, Ajji A, De Crescenzo G (2016) Fabrication and surface modification of poly lactic acid (PLA) scaffolds with epidermal growth factor for neural tissue engineering. Biomatter 6(1):e1231276
Zhao J, Han W, Tu M, Huan S, Zeng R, Wu H, Cha Z, Zhou C (2012) Preparation and properties of biomimetic porous nanofibrous poly(L-lactide) scaffold with chitosan nanofiber network by a dual thermally induced phase separation technique. Mater Sci Eng C 32(6):1496–1502
Lou T, Wang X, Song G, Gu Z, Yang Z (2014) Fabrication of PLLA/β-TCP nanocomposite scaffolds with hierarchical porosity for bone tissue engineering. Int J Biol Macromol 69:464–470
Binan L, Tendey C, De Crescenzo G, El Ayoubi R, Ajji A, Jolicoeur M (2014) Differentiation of neuronal stem cells into motor neurons using electrospun poly-L-lactic acid/gelatin scaffold. Biomaterials 35(2):664–674
Kontogiannopoulos KN, Assimopoulou AN, Tsivintzelis I, Panayiotou C, Papageorgiou VP (2011) Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications. Int J Pharm 409(1–2):216–228
Nguyen TTT, Ghosh C, Hwang SG, Tran LD, Park JS (2013) Characteristics of curcumin-loaded poly(lactic acid) nanofibers for wound healing. J Mater Sci 48(20):7125–7133
Leroueil-Le Verger M, Fluckiger L, Kim YI, Hoffman M, Maincent P (1998) Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 46(2):137–143
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Li, J., Ding, J., Liu, T., Liu, J.F., Yan, L., Chen, X. (2017). Poly(lactic acid) Controlled Drug Delivery. In: Di Lorenzo, M., Androsch, R. (eds) Industrial Applications of Poly(lactic acid). Advances in Polymer Science, vol 282. Springer, Cham. https://doi.org/10.1007/12_2017_11
Download citation
DOI: https://doi.org/10.1007/12_2017_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75458-1
Online ISBN: 978-3-319-75459-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)